Call to Action #5 – Adopting one ID for every uniquely offered genetic test The Genetic Testing Unit (GTU) is a five-digit alphanumeric character sequence for every uniquely marketed test, even after the test is no longer available. The industry should adopt this coding system as a standard today – so we can move forward. […]
The current lack of an ID for each unique genetic test raises the possibility of confusion among clinicians ordering tests and laboratories reporting them. This post explores a proposed solution and steps for implementing it.
Call to Action #4 – Technology companies building advanced genomic capabilities Tech products should clearly show their genomic capabilities and advance their integration of genomic data. Questions to Ask As we approach the electronic heath record (EHR) vendors, what questions should we ask about their products capabilities that support the implementation of clinical genomics? […]
Call to Action #3 – Insurance company coverage information Genetic testing costs have decreased substantially, which should eliminate payers having different policies for coverage and reimbursement. With genetic testing the third most common treatment for prior authorization, we need to streamline this process. Questions to Ask As we approach the heath insurance payers, what […]
Call to Action #2 – Medical specialty groups computable guidelines Medical specialty associations have scientifically developed clear guidelines for the use of clinical genomics in patient care. Now they need to drive requirements so that EHR systems support the computability of those guidelines. Questions to Ask As we approach the various medical specialty groups, […]
The adoption of clinical genomics as standard of care has been slow. In this blog post, we will examine the major issues affecting clinical adoption and discuss what needs to happen next.